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Abstract
The Zap1 transcription factor of Saccharomyces cerevisiae plays a central role in zinc homeostasis by controlling the
expression of genes involved in zinc metabolism. Zap1 is active in zinc-limited cells and repressed in replete cells. At the
transcriptional level, Zap1 controls its own expression via positive autoregulation. In addition, Zap1’s two activation
domains are regulated independently of each other by zinc binding directly to those regions and repressing activation
function. In this report, we show that Zap1 DNA binding is also inhibited by zinc. DMS footprinting showed that Zap1 target
gene promoter occupancy is regulated with or without transcriptional autoregulation. These results were confirmed using
chromatin immunoprecipitation. Zinc regulation of DNA binding activity mapped to the DNA binding domain indicating
other parts of Zap1 are unnecessary for this control. Overexpression of Zap1 overrode DNA binding regulation and resulted
in constitutive promoter occupancy. Under these conditions of constitutive binding, both the zinc dose response of Zap1
activity and cellular zinc accumulation were altered suggesting the importance of DNA binding control to zinc homeostasis.
Thus, our results indicated that zinc regulates Zap1 activity post-translationally via three independent mechanisms, all of
which contribute to the overall zinc responsiveness of Zap1.
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Introduction
The activity of transcriptional regulatory proteins can be
regulated by a variety of mechanisms. These include the control
of transcription factor expression, stability, subcellular localization,
DNA binding activity, and activation domain function. While the
activity of many transcription factors is regulated by only a single
mechanism, some are regulated at multiple levels. Multiple levels
of regulating a single transcription factor allow that factor to
respond to different signals. For example, the C/EBP transcription
factors are regulated at transcriptional, translational, and post-
translational levels [1]. These different mechanisms allow C/EBP
target gene expression to be controlled by cell differentiation,
hormone levels, MAP kinase cascades, and calcium signaling.
Another advantage of multiple regulatory mechanisms control-
ling the activity of a transcription factor is the combined effects
each mechanism can have on the response of that factor to a single
stimulus. For example, the yeast Pho4 transcription factor is
regulated in response to phosphate status by phosphorylation at
four different sites in the protein [2]. Phosphorylation at one site
inhibits the interaction of Pho4 with its partner protein, Pho2, thus
decreasing activation function. Phosphorylation at two other sites
in Pho4 promotes nuclear export of the protein while phosphor-
ylation at a fourth site inhibits Pho4 nuclear import. These dif-
ferent mechanisms of regulation are all required for full repression
of Pho4 activity by phosphate.
In this report, we address the multiple levels of regulation that
control the yeast Zap1 protein in response to zinc status. Zinc is an
essential nutrient for all organisms because of its many functions as
a structural and catalytic cofactor. Zinc is also potentially toxic to
cells when accumulated in high amounts. The essential but poten-
tially toxic nature of this metal necessitates precise homeostatic
control mechanisms. In E. coli, zinc homeostasis is accomplished
largely through the transcriptional control of zinc uptake and
efflux transporters [3,4]. Studies of the regulatory zinc sensors that
control expression of these transporters suggest that E. coli cells
strive to maintain essentially no free zinc in their cytosol [5].
Similarly, in eukaryotic cells, cytosolic free zinc levels are esti-
mated to be at or below nanomolar levels under steady state
growth conditions [6,7,8].
We know much about zinc homeostasis in eukaryotes from
studies of the yeast Saccharomyces cerevisiae. The Zap1 transcriptional
activator is a central player in the adaptation of these cells to zinc-
limiting conditions. Zap1 activates the expression of as many as 80
genes [9,10] and also represses the expression of other targets
through various mechanisms [11,12,13]. Genes induced by Zap1
encode proteins such as the plasma membrane zinc transporters
Zrt1, Zrt2, and Fet4, the vacuolar zinc transporters Zrt3 and Zrc1,
and other proteins involved in adaptation to zinc deficiency [9].
Zap1 is an 880-residue protein containing seven C2H2 zinc
fingers (Znf). Znf3-7 are located at the C-terminus (residues 705–
880) and comprise the DNA-binding domain. This domain is
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ZREs, found in one or more copies in Zap1’s target promoters
[14]. The consensus ZRE sequence is 59-ACCTTNAAGGT-39
and we have shown previously that Zap1 binds to this palindromic
sequence as a monomer and not as a dimer [15].
Zap1’s two activation domains, AD1 and AD2, are responsible
for increasing gene expression in response to low zinc. AD1 lies
between residues 207 and 402 and is embedded within a larger
region (residues 182–502) termed the Zinc-Responsive Domain of
AD1 (ZRD
AD1) that is required for controlling AD1 function [16].
Zap1 AD2 maps between residues 611 and 641, which are the
endpoints of the Znf2 zinc finger [17]. The ZRD for AD2
(ZRD
AD2) includes both Znf1 and Znf2. Studies to date indicate
that zinc regulates AD1 and AD2 directly by binding to ligand
residues in their respective ZRDs to repress activation domain
function [16,17].
While regulation of AD1 and AD2 clearly plays an important
role in Zap1 zinc responsiveness, other levels of control may also
contribute. For example, at the transcriptional level, Zap1 induces
its own expression in low zinc via positive autoregulation [18]. The
contribution of autoregulation to Zap1’s overall zinc responsive-
ness is unknown. In addition, activity of a fusion protein in which
the Zap1 DNA binding domain (residues 687–880) alone was
attached to the Gal4 activation domain (GAD-Zap1
DBD) was zinc
regulated [19]. This result suggested that zinc controls Zap1 DNA
binding. However, equally viable alternative mechanisms of zinc
regulation of this fusion protein included control of Zap1 nuclear
localization and recruitment of co-repressors (e.g. histone dea-
cetylases) to promoters by this domain. In this report, we have
tested these hypotheses and found that DNA binding activity is
indeed regulated by zinc. Furthermore, we present evidence that
this control is a critical component of Zap1’s zinc responsiveness.
Results
Some zinc regulation is mediated by the Zap1 DNA
binding domain in vivo
In wild-type cells that express Zap1 from its own promoter, a
Zap1-regulated ZRT1-lacZ reporter is highly induced by zinc
limitation and expressed at decreasing levels as the concentration
of zinc in the medium is increased (Figure 1A). zap1D cells
expressing wild-type Zap1 at a low level from the GAL1 promoter
(pZap1
WT) showed a similar response. Although this promoter is
highly induced by galactose, we grew these cells in glucose where
the level of Zap1 expression was similar to the level observed in
zinc-replete wild-type cells expressing Zap1 from its own promoter
[20] and much less than in galactose-grown cells (see below). To
assess whether zinc-regulated Zap1 DNA binding may contribute
to this response, we assayed zap1D cells expressing a mutant form
of the protein (Zap1
TC) in which AD1 and AD2 function is made
constitutive by mutating regulatory residues required for the zinc
responsiveness of those domains [16] (Figure 1A). As previously
shown, this mutant allele showed little zinc response under
moderate conditions (i.e. 3–300 mM Zn). However, when zinc was
added at higher levels (i.e. 1000 and 3000 mM), reporter
expression was reduced to approximately 30% of maximal levels.
These effects were confirmed when mRNA levels of ZRT1 and
ZPS1, two chromosomal targets of Zap1, were assayed under low
and high zinc conditions (Figure 1B, C). It should be noted that
LZM, the medium used in these and subsequent experiments,
contains 1 mM EDTA and 20 mM citrate as metal buffers to limit
zinc availability. Therefore, even at high total zinc concentrations
(e.g. 1000 or 3000 mM) the level of free Zn
2+ in the medium
available to cells is less than what is found in standard yeast culture
media (i.e. YPD or SD) [21]. CMD1, encoding calmodulin, was
used as a negative control and its levels were not altered by zinc
status.
ZRE occupancy is regulated by zinc status in vivo
The observation that the Zap1
TC protein and the GAD-
Zap1
DBD fusion [19] retain substantial zinc regulation suggested
the possibility that Zap1 DNA binding activity was controlled by
zinc. To test this hypothesis, we first used in vivo dimethyl sulfate
(DMS) footprinting to examine occupancy of a Zap1 binding site
(ZRE1) in the ZRT1 promoter [22]. In a zap1D mutant grown in
zinc-limiting (Figure 2A) or replete (data not shown) conditions, a
cluster of purine nucleotides within the ZRE was readily accessible
to methylation by DMS. In zinc-limited wild-type cells where
Zap1-activated transcription is high, these ZRE residues were
largely protected from methylation consistent with Zap1 occupy-
ing the site in vivo. With increasing zinc levels, ZRE protection
decreased suggesting loss of Zap1 binding. To quantify the effects
of zinc on ZRE occupancy, the experiment shown in Figure 2A
was repeated six times, the band intensities were measured, and
the results are plotted in Figure 2B. Fractional ZRE protection in
zinc-limited wild-type cells was estimated to be 68% (setting the
methylation level observed in a zap1D mutant at 0% protection)
(see Materials and Methods). Less than 100% methylation
protection may be observed if there is incomplete ZRE occupancy
in low zinc or only partial protection by bound protein. In zinc-
replete (e.g. LZM+1000 mM zinc) wild-type cells, methylation
protection dropped to ,10% indicating a dramatic loss of Zap1
binding.
Zap1 controls its own transcription via positive autoregulation.
Therefore, the effects of zinc on ZRE occupancy in wild-type
cells could result solely from changes in Zap1 protein level. To
assess this possibility, we first determined the level of Zap1 pro-
tein expressed under these conditions by immunoblot analysis
(Figure 2C). Consistent with the effects previously observed for
ZAP1 mRNA [10,18], Zap1 protein levels were highest in zinc-
limited cells and decreased as the zinc concentration of the
medium was raised. Little effect of zinc status on the level of a
control protein, the Pgk1 3-phosphoglycerate kinase, was ob-
served. Having shown previously that zinc does not trigger
degradation of Zap1 protein [16], these data indicated that ZAP1
transcriptional autoregulation does indeed cause corresponding
changes in Zap1 protein level. Therefore, the apparent loss of
ZRT1 ZRE occupancy observed in wild-type cells grown in high
zinc could be due to decreased Zap1 DNA binding activity and/
or decreased Zap1 protein level resulting from transcriptional
autoregulation.
Zinc regulation of ZRE occupancy does not require Zap1
transcriptional autoregulation
To determine the contribution of autoregulation to controlling
Zap1 binding, we examined ZRE occupancy using glucose-grown
cells expressing Zap1 at a low constitutive level from the GAL1
promoter. An epitope-tagged allele was used in which six myc
epitopes were fused to the N-terminus of Zap1 to facilitate
immunoblot detection. Notably, myc-Zap1 expressed from the
GAL1 promoter in glucose fully complemented a zap1D mutant for
ZRT1-lacZ expression (Figure 1A). Immunoblotting confirmed
that myc-Zap1 protein levels were similar in low and high zinc
(Figure 3A). Using in vivo DMS footprinting, we found that
protection of the ZRT1 ZRE from methylation was apparent in
zinc-limited cells and this protection decreased in high zinc
(Figure 3B). To ensure the reproducibility of this result, we
performed this experiment six times, quantified the intensities of
Zinc Regulation of Zap1 DNA Binding
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Figure 3C alongside the wild type data from Figure 2. Zinc-
regulated promoter occupancy was clearly observed in cells
expressing Zap1 at a low constitutive level without autoregulation.
Thus, the differential ZRE occupancy observed in wild-type cells is
not due solely to changes in Zap1 protein level.
To confirm these results using a different method, we used
chromatin immunoprecipitation to assess ZRE occupancy in vivo.
Again, myc-tagged Zap1 was expressed at a low level from the
GAL1 promoter in glucose-grown cells. When myc-Zap1 was
immunoprecipitated from cross-linked chromatin, ZRE-contain-
ing promoter regions of ZRT1 and ZPS1 co-immunoprecipitated
in samples from low zinc cells (Figure 4). Co-immunoprecipita-
tion of these promoters was greatly reduced in high zinc cells. The
CMD1 promoter was used as a negative control and was not
immunoprecipitated from either low- or high-zinc grown cells.
These results confirm that Zap1 ZRE occupancy is zinc regulated
in the absence of transcriptional autoregulation.
Zinc regulation of ZRE occupancy occurs without
changes in nuclear Zap1 localization
We previously demonstrated that Zap1’s nuclear localization
does not change in response to zinc status but those experiments
were performed with cells overexpressing Zap1 to allow its
detection by immunofluorescence microscopy [19]. Such overex-
pression conditions could potentially override zinc regulation of
Zap1 subcellular distribution. Therefore, to examine Zap1 distri-
bution at its normal low level of expression, we used immuno-
blotting to assay Zap1 levels in total lysates, cytosol, and isolated
nuclei. Zap1 was expressed at a low constitutive level from the
GAL1 promoter in cells grown in glucose with low and high zinc.
As shown in Figure 5, Zap1 levels were low in total lysates and
cytosol but were highly enriched in nuclei regardless of zinc status.
Pgk1 was used as a cytosolic protein marker and Dpm1 and Pho2
were markers for nuclei. Their distributions in these fractions
confirmed our nuclear isolation method. These results demon-
strate that Zap1 nuclear localization is not regulated by zinc status.
Therefore, our DMS footprinting and chromatin immunoprecip-
itation results (Figures 2, 3, and 4) suggested that Zap1’s DNA
binding activity per se is regulated by zinc.
Zinc regulation of ZRE binding maps to the Zap1 DNA
binding domain
Zinc regulation of the GAD-Zap1
DBD fusion protein [19]
suggested that control of ZRE occupancy maps to the DNA
binding domain alone. To assess this hypothesis directly, we tested
whether a Zap1 truncate containing only the DNA binding
domain showed zinc-regulated ZRE occupancy in vivo. For this
purpose, we used a myc-tagged deletion mutant in which amino
acids 17-700 of Zap1 were deleted (Figure 6A). When expressed
from the GAL1 promoter at low levels, Zap1
D17-700 accumulated to
similar levels regardless of zinc status (Figure 6B). Chromatin
immunoprecipitation indicated that in vivo ZRE occupancy of this
truncated Zap1 protein was still zinc regulated (Figure 6C).
These results indicate that this property maps to the Zap1 DNA
binding domain alone and does not require other regions of the
Zap1 protein.
Figure 1. Possible zinc regulation of the Zap1 DNA binding
domain in vivo.A ) Wild-type (DY1457) or zap1D (ZHY6) cells
transformed with either pZap1
WT, pZap1
TC, or the pYef2 vector and
the pGI-1 ZRT1-lacZ reporter were grown to exponential phase in LZM
supplemented with the indicated concentration of ZnCl2 prior to
analysis of b-galactosidase activity. Zap1
TC has mutations in the zinc-
responsive domains of Zap1’s two activation domains rendering those
domains constitutive. ZRT1 encodes a plasma membrane zinc uptake
transporter and is a Zap1 target gene. Values plotted are the means of
three replicate cultures and the error bars indicate 61 S.D. B) Total RNA
was extracted from the cells described in panel A grown in LZM
supplemented with 3 mM or 1000 mM ZnCl2 and S1 nuclease assays
were performed to determine mRNA levels of ZRT1 and ZPS1, another
Zap1 target gene that encodes a secreted protein of unknown function.
CMD1 was used as a loading control. C) Graphical representation of
results obtained in panel B.
doi:10.1371/journal.pone.0022535.g001
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function and zinc homeostasis
In the course of these studies, we found that the control of DNA
binding activity was sensitive to the level of Zap1 expression.
When zap1D cells bearing the GAL1-driven ZAP1 gene were grown
in galactose or overexpression was achieved using the GEV hybrid
activator protein and high levels of the b-estradiol inducer, Zap1
protein accumulated to levels much higher than were observed in
uninduced, glucose-grown cells (Figure 7A). The higher level of
Zap1 accumulation in zinc-replete cells overexpressing the protein
is likely an artifact of the expression system used and has been
previously observed [16]. Zap1 accumulation in glucose-grown
cells was below the level of detection on this blot. The multiple
bands observed in samples from Zap1-overexpressing cells are
likely due to some proteolysis of the protein. When Zap1 was
expressed at these high levels and ZRE occupancy was assayed by
in vivo DMS footprinting, the ZRT1 ZRE was protected from
methylation regardless of zinc concentration indicating constitu-
tive Zap1 binding (Figure 7B). This conclusion was confirmed by
chromatin immunoprecipitation of Zap1 on the ZRT1 promoter in
both high and low zinc (Figure 7C). Thus, high-level Zap1
Figure 3. Zap1 DNA binding is controlled in vivo without
autoregulation. A) ZHY6 zap1D mutant cells transformed with either
pZap1
WT or the vector pYef2 were grown to exponential phase in
LZM+3 mM and LZM+1000 mM ZnCl2. LZM contains 2% glucose as
carbon source so expression of Zap1 from the GAL1 promoter is at low
levels similar to endogenous Zap1. Total protein extracts were prepared
and subjected to immunoblot analysis using antibodies against Zap1
(myc) and Pgk1. B) ZHY6 zap1D cells transformed with the vector
(pYef2) or pZap1
WT were grown to exponential phase in LZM+3o r
1000 mM zinc. Cells were than analyzed by in vivo DMS footprinting. The
box indicates the position of the ZRE and the bands used for
quantification of protection. C) The experiment shown in Figure 3B
was repeated a total of six times and quantified as described in the
Materials and Methods. The mean percent protection levels are shown
and the error bars indicate 1 S.D. Data for wild-type cells from Figure 2B
are shown again here for comparison.
doi:10.1371/journal.pone.0022535.g003
Figure 2. ZRE occupancy by Zap1 is altered by zinc status in
vivo.A ) Wild-type (DY1457) cells were grown to exponential phase in
LZM supplemented with the indicated concentration of ZnCl2 and
analyzed by in vivo DMS footprinting on the ZRT1 promoter. A sample
from a ZHY6 zap1D mutant grown in LZM+3 mM ZnCl2 is shown for
comparison. The position of the ZRE was determined using a DNA
sequencing ladder (not shown) and is indicated by the box. The
sequence of the ZRE is shown with the distance of those bases from the
ATG start codon; the purines that are sensitive to DMS methylation are
italicized. The ZRE bands used to quantify protection are marked by
asterisks and boxed. B) The experiment shown in Figure 2A was
repeated a total of six times and quantified as described in the Materials
and Methods. The mean percent protection levels are shown and the
error bars indicate 1 S.D. C) Immunoblot analysis of Zap1 and Pgk1
levels in the same cells as in Figure 2A. Total protein extracts were
prepared from aliquots of cells harvested prior to DMS treatment.
doi:10.1371/journal.pone.0022535.g002
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binding activity.
This observation was useful because it allowed us to test the
importance of DNA binding regulation to overall Zap1 zinc
responsiveness. Zap1 was expressed in a zap1D mutant at low
levels, such that DNA binding domain control was operable, and
at high levels where binding was constitutive. When assayed for
expression of the ZRT1-lacZ reporter, regulation by overexpressed
Zap1 was clearly defective over a wide range of zinc levels and
higher levels of zinc were required for ZRT1-lacZ expression to be
inhibited (Figure 8A). One possible explanation for this effect is
that the higher Zap1 protein levels in an overexpressing cell may
bind significant amounts of zinc and consequently alter zinc
homeostasis. However, we found that this is unlikely to be the case.
Overexpression of a Zap1 mutant allele where key DNA binding
residues (i.e. zinc finger a-helical
-1,3,6 residues) in zinc finger 4
were mutated to alanines [15] had no effect on the zinc
Figure 6. Zinc regulation of Zap1 ZRE binding maps to the DNA
binding domain. A) Diagram of wild-type Zap1 and Zap1
D17-700. The
latter allele retains only a small part of the N-terminus of the protein
and the intact DNA binding domain. The hatched boxes indicate the
activation domains and the black boxes numbered 1–7 denote the
zinc fingers. B)Z H Y 6zap1D cells transformed with pPGK-ZRT1,
and either pZap1
WT, pZap1
D17-700, or the pYef2 empty vector were
grown to exponential phase in LZM supplemented with 3 mMo r
1000 mM ZnCl2. pPGK-ZRT1 expresses the high affinity ZRT1 zinc
transporter from the PGK1 promoter allowing a cell with no functional
Zap1 to grow well in low zinc. Total protein extracts were prepared and
subjected to immunoblot analysis using antibodies against Zap1 (myc)
and Pgk1. C) The same cells as described in panel B were grown to
exponential phase and chromatin immunoprecipitation analysis was
performed using primers flanking the ZRE in ZRT1. Primers specific for
the promoter region of CMD1 were used as a negative control. The
shown inputs are 1000-fold dilutions of whole cell extracts and 10-fold
serial dilutions of representative samples are included to confirm the
quantitative nature of the assay.
doi:10.1371/journal.pone.0022535.g006
Figure 4. Confirmation of regulated Zap1 ZRE occupancy by
chromatin immunoprecipitation. ZHY6 zap1D cells transformed
with pZap1
WT were grown to exponential phase in LZM+3 mMo r
1000 mM ZnCl2. Wild-type (DY1457) cells transformed with pYef2 vector
were used as a negative control. Cells were then harvested and
chromatin immunoprecipitation was performed using primers flanking
the ZREs in ZRT1 and ZPS1. Primers specific for the promoter region of
CMD1 were used as a negative control. Shown inputs are 1000-fold
dilutions of whole cell extracts, and 10-fold serial dilutions of
representative samples were also PCR amplified to confirm the
quantitative nature of the assay.
doi:10.1371/journal.pone.0022535.g004
Figure 5. The nuclear localization of Zap1 is not affected by
zinc. Protease-deficient BJ2168 cells transformed with pZap1
WT were
grown to exponential phase in LZM supplemented with 3 mMo r
1000 mM ZnCl2. BJ2168 cells lacking pZap1
WT were also grown in LZM
supplemented with 1000 mM ZnCl2. Total cell homogenates were
separated into cytosolic and nuclear fractions as described in Materials
and Methods. Equal amounts of protein from each sample (10 mg
protein/lane) were assayed by immunoblotting using antibodies
against Zap1 (myc), Pgk1, Dpm1, and Pho2.
doi:10.1371/journal.pone.0022535.g005
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protein accumulated to the same level as the wild-type protein
(Figure 8C) and is unable to bind DNA [15]. Because this
mutation does not alter any zinc ligands of zinc finger 4, the
mutant protein’s ability to bind zinc there and at other sites in
Zap1 is unlikely to be affected [23]. Therefore, we conclude that a
high level of zinc binding by overexpressed Zap1 protein is not
responsible for the altered transcriptional response observed in
Figure 8A. In addition, these data indicate that high level
expression of functional Zap1 activation domains also does not
alter Zap1’s zinc responsiveness.
These results show that regulation of Zap1 DNA binding is
important for the zinc responsiveness of Zap1 transcriptional
regulation. To assess its importance to zinc homeostasis, we
assayed zinc accumulation in cells with or without DNA binding
control. An effect on zinc accumulation would reflect misregula-
tion of the zinc uptake transporters. Wild-type cells and zap1D cells
expressing either low or high levels of Zap1 were grown in LZM
supplemented with 3, 10, 30 and 100 mM Zn and tracer amounts
of
65Zn to assess total zinc accumulation. After ,5 generations of
growth in these media, the cells were harvested, washed to remove
surface-bound zinc, and assayed for accumulation. As shown in
Figure 8D, cells overexpressing Zap1, and therefore lacking
DNA binding control, accumulated higher levels of total zinc than
did wild-type cells and zap1D cells expressing low levels of Zap1.
These results support the hypothesis that DNA binding control is
critical for maintaining zinc homeostasis in these cells.
Discussion
In this report, we have shown that Zap1 DNA binding activity is
regulated by zinc status. This conclusion is based on our
observations that ZRE occupancy is altered in response to zinc
without any changes in the total level of Zap1 or the nuclear
Figure 7. Overexpressing Zap1 protein overrides zinc regulation of DNA binding activity. A) Wild-type (DY1457) or ZHY6 zap1D cells
transformed with pGEV and pZap1
WT were grown to exponential phase in LZM supplemented with 3 mM or 1000 mM ZnCl2. For low-level Zap1
expression, 2% glucose (Glu) was used as the carbon source. pGEV encodes a hybrid activator protein that contains the Gal4 DNA binding domain,
the VP16 activation domain, and the hormone-response domain of the human estrogen receptor. For high-level expression, cells were grown in
either 2% galactose (Gal) or glucose +1 mM b-estradiol (bE). Total protein extracts were prepared and subjected to immunoblot analysis using
antibodies against Zap1 (myc) and Pgk1. The asterisk marks full-length myc-Zap1; the lower bands likely represent proteolytic fragments. B) Wild-type
(DY1457) or ZHY6 zap1D cells transformed with pZap1
WT were grown to exponential phase in LZM supplemented with 3 mM or 1000 mM ZnCl2. For
low-level Zap1 expression, 2% glucose (Glu) was used as the carbon source. To induce high Zap1 expression, 2% galactose (Gal) was used. In vivo
DMS footprinting analysis was then performed. The box marks the position of the ZRE. C) ZHY6 zap1D cells transformed with either pZap1
WT or pYef2
vector were grown to exponential phase in LZM supplemented with 3 mM or 1000 mM ZnCl2. For low-level Zap1 expression, 2% glucose (Glu) was
used as the carbon source. For high-level Zap1 expression, cells were either grown in the presence of 2% galactose (Gal) or glucose+1 mM b-estradiol
(bE). Chromatin immunoprecipitation analysis was performed using primers flanking the ZRE of the ZRT1 promoter. Primers specific to the promoter
region of CMD1 were used as a negative control. The shown inputs represent 1000-fold dilutions of whole cell extracts and 10-fold serial dilutions of
representative samples are included to confirm the quantitative nature of the assay.
doi:10.1371/journal.pone.0022535.g007
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in vivo DMS footprinting and chromatin immunoprecipitation.
One limitation of the footprinting method is that it does not
definitively show that the protein protecting the ZRE is Zap1 and
not some other transcription factor. However, several observations
support the conclusion that the methylation protection observed is
due to Zap1 binding. First, no protection was detected in a zap1D
mutant and protection was constitutive in a Zap1-overexpressing
strain. Second, in vitro studies have shown that purified Zap1 binds
to ZREs with high sequence specificity and affinity [14]. Elec-
trophoretic mobility shift assays (EMSAs) using protein extracts
prepared from cells indicated that Zap1 in these crude pre-
parations binds to the ZRE (C. Srinivasan and D. Winge,
unpublished). Specifically, protein-ZRE complexes observed with
extracts from cells expressing myc-Zap1 could be super-shifted
with anti-myc antibody. Finally, and most importantly, the DMS
footprinting results were confirmed using an independent method,
chromatin immunoprecipitation, which allowed us to directly
show the regulated association of Zap1 with ZREs in vivo.
With the addition of DNA binding control, we now know that
Zap1 activity is regulated by zinc via multiple mechanisms. Two of
these mechanisms involve the regulation of Zap1’s two activation
domains. Our previous studies showed that zinc controls AD1 and
AD2 independently of each other. This regulation likely occurs
through the binding of zinc directly to residues within and flanking
these activation domains. We hypothesize that zinc binding to
these domains folds them into inactive conformations that are
incapable of recruiting coactivators to Zap1 target promoters. We
have also shown in previous studies that ZAP1 gene expression is
under positive transcriptional autoregulation. Here we confirm
that this transcriptional control does indeed alter Zap1 protein
levels.
Having so many different mechanisms of zinc responsiveness
raises the issue of what each of these mechanisms contributes to
Zap1 regulation and zinc homeostasis. With regard to transcrip-
tional autoregulation, we found no obvious effect on regulation of
a ZRT1-lacZ reporter when we eliminated that mechanism of
control by expressing Zap1 at a constant low level from the GAL1
promoter. However, we note that the ZRT1 promoter contains
four high affinity ZREs and therefore may be less sensitive to
changes in Zap1 level than other promoters with lower affinity
binding sites. This hypothesis is supported by our recent
Figure 8. Overexpressing Zap1 disrupts gene regulation and zinc homeostasis. A) ZHY6 zap1D cells transformed with pGEV, the pGI-1
ZRT1-lacZ reporter and either pZap1
WT or pYef2 vector were grown to exponential phase in LZM supplemented with the indicated concentration of
ZnCl2. To induce high Zap1 expression, cells were treated with 1 mM b-estradiol (ox). Cells were then harvested and b-galactosidase assays were
performed. B) Wild-type DY1457 cells transformed with pGEV, the pGI-1 ZRT1-lacZ reporter, and either pYef2 or pZap1
mZnf4 were grown to
exponential phase in LZM supplemented with the indicated concentration of ZnCl2. To induce high Zap1
mZnf4 levels, cells were treated with 1 mM b-
estradiol (ox). Cells were then harvested and b-galactosidase assays were performed. The values shown in panels A and B are the means of three
independent cultures, and the error bars equal 61 S.D. C) Protein extracts were generated from the samples described in panels A and B and
subjected to immunoblot analysis using antibodies against Zap1 (myc) and Pgk1. D) Wild-type DY1457 cells and ZHY6 zap1D cells transformed with
pGEV and either the pYef2 vector or pZap1
WT were inoculated at an A600 of 0.02 in LZM supplemented with the indicated concentration of ZnCl2 plus
tracer amounts of
65ZnCl2. To induce high levels of Zap1
WT protein expression, cultures were treated with 1 mM b-estradiol (Zap1
WTox). Cultures were
grown to an A600 of ,0.75, after which zinc accumulation was measured. Shown are the means of three independent cultures and the error bars
indicate 61 S.D. The asterisks indicate a significant difference (p,0.05) of zap1D cells expressing Zap1
WTox relative to Zap1
WT controls as determined
by 2-sided Student t-test.
doi:10.1371/journal.pone.0022535.g008
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to be induced only under the most severe zinc-limiting conditions
when Zap1 protein levels are highest [9]. We therefore propose
that transcriptional autoregulation of ZAP1 expression may play a
significant role on those promoters.
From our analysis of activation domain and DNA binding
domain regulation, it is clear that these post-translational mecha-
nisms are integrated to control the overall response of Zap1 to
zinc. When comparing AD1 and AD2 function, we have found
that AD1 is responsible for dictating the zinc dose response and
induction kinetics of most Zap1 target genes [20]. In contrast,
AD2 is required for full induction of only a few Zap1 targets. AD2
appears to play a more important role when zinc deficiency is
combined with other stresses such as heat stress or carbon source
limitation. Our studies of DNA binding regulation reported here
suggest that this level of control also plays a major role in
determining the zinc dose response of Zap1; when DNA binding
was rendered constitutive by overexpression, Zap1 activity was
much less responsive to zinc and zinc homeostasis was disrupted.
Another potential role for Zap1 DNA binding regulation is that it
may also contribute during transitions in zinc status. However, we
found that constitutive Zap1 binding did not affect the rate at
which ZRT1 mRNA levels decreased following zinc treatment of
zinc-limited cells, suggesting this is not the case (A. Frey, data not
shown).
How might zinc control Zap1 DNA binding? We mapped the
regulation of DNA binding activity to the Zap1 DNA binding
domain alone. The five zinc fingers of the DNA binding domain
are all high affinity structural zinc sites and these domains have
metal bound even in zinc-limited cells. Our previous studies
demonstrated that binding of zinc by each of the five fingers is
required for ZRE binding [14]. One or more low affinity
regulatory zinc-binding sites may also be present in the DNA
binding domain. When intracellular zinc rises to sufficiently high
levels, this regulatory site could then bind zinc and interfere with
DNA binding, perhaps by promoting inhibitory finger-finger
interactions. We have tested this model in vitro but these
experiments did not support the hypothesis. Using both electro-
phoretic mobility shift assays and surface plasmon resonance
analysis, we have determined that Zn
2+ at concentrations as high
as 10 mM does not inhibit ZRE binding by purified Zap1 (M.
Evans-Galea and D. Winge, unpublished). This value is much
higher than the nanomolar (or lower) levels of free zinc [6,7,8]
found within cells. Higher concentrations of zinc did inhibit Zap1
ZRE binding in vitro but this effect was nonspecific and those levels
of zinc also interfered with in vitro DNA binding of control proteins
(Gal4, Swi5) that function well in zinc-replete cells. Thus,
inhibition of DNA binding by zinc ions binding directly to
the Zap1 DNA binding domain appears unlikely to be the
mechanism that operates in vivo. An alternative model is that DNA
binding activity is controlled by post-translational modification,
such as phosphorylation. This form of DNA binding regulation
has been demonstrated for other C2H2 zinc finger transcription
factors, such as Adr1 [24]. Other work has shown that phos-
phorylation of the canonical TGEKP zinc finger linker region
causes a strong reduction in DNA-binding affinity of C2H2 zinc
finger proteins [25,26]. Future studies will address further details
regarding this mechanism of Zap1 DNA binding regulation.
Materials and Methods
Growth conditions
All yeast strains were grown in either YP medium supplemented
with 2% glucose (YPD) or synthetic defined medium with 2%
glucose and the appropriate auxotrophic supplements. Limiting
zinc medium (LZM) was prepared as previously described [27]
with either 2% glucose or 2% galactose as the carbon source and
the indicated concentration of ZnCl2. LZM contains 1 mM
EDTA and 20 mM citrate as metal buffers to limit zinc avail-
ability. It is important to note that even when supplemented with
1000–3000 mM zinc, LZM has lower free Zn
2+ available to cells
than is found in standard yeast culture media such as SD or YPD.
Regulated expression from the GAL1 promoter in glucose-
containing media was achieved using the GEV system. The
GEV protein contains the Gal4 DNA binding domain, the VP16
activation domain, and the hormone-response domain of the
human estrogen receptor. Treatment of GEV-containing cells with
b-estradiol results in increased expression of genes expressed from
the GAL1 promoter [28].
Yeast strains and plasmids
The yeast strains used in this study were DY1457 (MATa ade6
can1 his3 leu2 trp1 ura3), ZHY6 (DY1457 zap1D::TRP1) [18], and
BJ2168 (MATa leu2 trp1 ura3 prb1 pep4 prc1 gal2) [29]. The ZRT1-
lacZ reporter construct used in this study was pGI-1 [22]. Plasmid
pGI-1 contains the entire ZRT1 promoter (2521 to the ATG start
codon) fused to lacZ. The construction of pZap1
WT (previously
referred to as pMyc-Zap11–880), a plasmid containing an N-
terminal myc-tagged ZAP1 allele under the control of the GAL1
promoter in the vector pYef2, was described previously [19].
pZap1
TC was generated as previously described (21). pZap1
D17-700
was made by generating the corresponding open reading frame by
overlap PCR and inserting the resulting fragment into BstX1-
linearized pZap1
WT using homologous recombination. To create
pPGK-ZRT1, a cloning strategy was used in which the ZRC1
open reading frame in the construct pPGK-ZRC1 (C. W.
MacDiarmid, unpublished) was replaced with ZRT1 using homo-
logous recombination. Primers were designed such that the 59
primer contained 40 bp of homology to the PGK1 promoter region
and 20 bp of homology to the 59 end of ZRT1 and the 39 primer
contained 40 bp of homology to the ZRC1 terminator and 20 bp
of homology to the 39 end of ZRT1. The resulting PCR product
was co-transformed into DY1457 with BamHI-digested pPGK-
ZRC1 and transformants selected on SD media for the plasmid
URA3 marker. Plasmids were then rescued from DY1457 using
standard procedures. The resulting construct containing ZRT1
fused to the PGK1 promoter and ZRC1 terminator was confirmed
by DNA sequencing.
In vivo dimethyl sulfate footprinting
Thirty ml cultures were grown for 15–20 h to mid-exponential
phase (A600=0.3–0.7) in LZM supplemented with the indicated
amount of ZnCl2. Cells were treated with DMS (30 ml/30 ml of
culture) for 7 min and then harvested by centrifugation. Isolation
of genomic DNA and in vivo footprinting analysis were performed
as previously described [30]. The oligonucleotide used for primer
extension analysis (Table 1) hybridizes to the ZRT1 promoter at
positions 2481 to 2460 relative to the initiation codon. Quan-
tification of band intensities was performed using a Storm 860
PhosphorImager (Molecular Dynamics) with ImageQuant soft-
ware. Calculation of the fractional protection of residues was
performed as follows [31]: Fractional protection (in percent)
=12[(BIZRE/BIstandard)/(BIZRE in zap1D/BIstandard in zap1D)]
6100 where BIZRE and BIstandard refer to the band intensities of
the affected ZRE residues and of a control band elsewhere in the
primer extension ladder that was unaffected by zinc or ZAP1
genotype. Similar results were obtained when ZRE protection was
quantified relative to several different control bands.
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Chromatin immunoprecipitation was performed as described
[32]. Wild-type cells transformed with either the vector (pYef2)
or a plasmid expressing a myc-tagged Zap1 protein (pZap1
WT)
were grown to an A600 ,0.5 and then treated with 1% for-
maldehyde to cross-link protein-DNA complexes. The cross-
linking reaction was quenched by adding 125 mM glycine. After
two washes with ice-cold PBS, the cells were lysed with glass
beads in buffer containing Complete Protease Inhibitor Cocktail
(Roche), 1 mM PMSF, and 2 mM benzamidine. Following
centrifugation for 10 minutes at 16,0006 g, the supernatants
were incubated with anti-myc antibody at 4uC overnight and
immune complexes isolated with Protein A-Sepharose. The cross-
links were reversed in TES and co-immunoprecipitation of specific
promoter fragments with myc-Zap1 was assessed by PCR using
primers flanking the ZRT1 and ZPS1 ZREs (Table 1). Primers
specific to the CMD1 promoter were used as a negative control.
PCR products generated from 10-fold serially diluted input
samples were used to confirm the quantitative nature of the
analysis.
Immunoblot analysis
Protein extracts for immunoblots were prepared by two
different procedures. Subcellular fractionation analysis was
performed as described previously [33] with the following
modifications. Cells were grown to exponential phase in LZM
supplemented with the indicated amount of ZnCl2. Spheroplasts
generated by zymolyase (Zymo Research) digestion were resus-
pended in an 18% Ficoll buffer (20 mM potassium phosphate,
pH 6.5, 0.5 mM MgCl2 and 18% Ficoll) and were disrupted using
a Dounce homogenizer. Following removal of cell debris by
centrifugation at 50006g for 15 min, nuclei and other organelles
were separated from the cytosolic fraction by centrifugation at
25,0006g for 30 min. The pellet was resuspended in 18% Ficoll
buffer before being layered onto 35% Ficoll in the same buffer and
the nuclei sedimented at 100,0006 g for 90 minutes. All buffers
during and after the disruption of spheroplasts contained 1 mM
PMSF, 1 mM EDTA and the Complete Protease Inhibitor
Cocktail (Roche). The protease-deficient strain BJ2168 was
required for these experiments due to the extreme sensitivity of
Zap1 to proteolytic degradation during sample preparation from
wild-type cells. Total protein extracts for immunoblots were
prepared by cell disruption and protein precipitation in the
presence of trichloroacetic acid as described [34]. Immunoblots
were performed essentially as described [35]. All proteins were
separated by SDS-PAGE (7.5% acrylamide) and then transferred
to nitrocellulose. Blots were probed with anti-Zap1 [15], anti-c-
myc (monoclonal 9E10, Roche), or anti-Pgk1 (Molecular Probes)
antibodies, washed and then incubated with either goat anti-
mouse or goat anti-rabbit IgG antibodies coupled to horseradish
peroxidase. Detection was by enhanced chemiluminescence (ECL;
Amersham).
S1 nuclease protection assays
RNA was extracted from cells grown to mid-log phase using hot
acid phenol extraction. S1 analysis was performed as previously
described [36]. Ten mg of total RNA was hybridized to a
32P end-
labeled oligonucleotide probe before digestion by S1 nuclease and
separation on an 8% polyacrylamide/8 M urea gel. Probes used
are listed in Table 1. Band intensities were quantified by
phosphorimager analysis.
b-galactosidase assays
Cells were grown for 15–20 h to mid-exponential phase
(A600=0.3–0.7) in LZM supplemented with the indicated amount
of ZnCl2. b-galactosidase activity was measured as described [37]
and activity units were calculated as follows: (DA42061000)/
(min6ml of culture6absorbance of the culture at 595 nm).
Zinc accumulation assay
Cells were grown in LZM medium supplemented with the
indicated concentration of ZnCl2 including
65ZnCl2 added in
tracer amounts. The cells were grown to an A600 of ,0.75,
harvested by filtration on glass fiber filters, washed three times with
ice cold SSW (1 mM EDTA, 20 mM sodium citrate pH 4.2), and
then counted using a Wallac 1480 Wizard
TMgamma counter.
Cell-associated
65Zn was then adjusted for specific activity and
normalized by converting the culture A600 values to cell number
with a standard curve.
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Table 1. Oligonucleotides used in this study.
Gene Purpose Sequence
CMD1 S1 59-gggcaaaggcttctttgaattcagcaatttgttcttcggtggagcc-39
ZRT1 S1 59-ggccacacagattggtgtggttaacccatacgcaacacatagggcccatggccacctgatgcca-39
ZPS1 S1 59-ggcacccttggaaagcctccatcaattgctcaaagacacccatgacggtgaaaatactaccattaccgggttg-39
ZRT1 in vivo footprinting 59-gaacatggcgcaagtactta-39
CMD1 ChIP (f9)5 9-cctccaatcttaccgaaga-39
CMD1 ChIP (r9)5 9-gcgggagcaaaaaatcaca-39
ZRT1 ChIP (f9)5 9-caatacacccgtactctcttgcctgt-39
ZRT1 ChIP (r9)5 9-tgctctcaacctactttccatgac-39
ZPS1 ChIP (f9)5 9-tcgacaatgacatggcggaag-39
ZPS1 ChIP (r9)5 9-gaggttacattcttgtaagcag-39
doi:10.1371/journal.pone.0022535.t001
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